Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tailoring Disease Screening Programs to Individuals

Published: Friday, March 21, 2014
Last Updated: Friday, March 21, 2014
Bookmark and Share
To address the current one size fits all approach a NSF-funded scientist has developed a computer algorithm that will allow women to reach a decision customized for them.

Oguzhan Alagoz believes that many existing disease screening programs all too often take a one-size-fits-all approach. To be sure, "it is important to catch a disease early," he says. "But still, most screening programs treat everyone the same."

In breast cancer, for example, "they say any woman who turns 40, or 50, should start screening every year, and they don't differentiate women by individual risks," says Alagoz, an associate professor of industrial and systems engineering at the University of Wisconsin-Madison.

"The common characteristic of all of these guidelines is age," he adds. "They specify age, but don't specify whether women with higher or lower risk should or should not be screened, nor do they take into consideration a woman's personal preferences about mammography. We have to start tailoring screening recommendations to the individual woman."

To try to address this, the National Science Foundation (NSF)-funded scientist has developed a computer algorithm that will allow women to reach a decision customized for them. "You enter your age, your risk factors and how you personally feeling about screening," he says. "Then our model helps you make a decision about mammography."

Although implementation is beyond the scope of his research, he believes the ideal scenario would be to have a woman use the computer model in consultation with her personal physician. "We shouldn't over-trust the model," says Alagoz, who also holds a secondary appointment as an associate professor of population sciences in the university's school of medicine and public health.

"Over-trusting technology in medicine may not be the best thing to do, but it will help you," he adds. "It also will help the physician and the women who might be missing certain things. I see this not as a method to guide the whole decision, but as a decision support tool."

Ultimately, he sees the research as a framework for developing better screening policies for other cancers as well, including prostate and colorectal cancers as well as other conditions, such as diabetic retinopathy.

"Any improvement on cancer screening and diagnosis would directly affect millions of people being screened for cancer, and indirectly affect almost the whole population being screened for other diseases," he says. "Furthermore, the potential life savings and dollar savings of the proposed research are substantial."

Alagoz is conducting his work with an NSF Faculty Early Career Development (CAREER) award, which he received in 2009 as part of the American Recovery and Reinvestment Act. The award supports junior faculty who exemplify the role of teacher-scholars through outstanding research, excellent education, and the integration of education and research within the context of the mission of their organization. NSF is funding his work with about $430,000 over five years.

As part of the grant's educational component, he is training doctoral students to use such operations research techniques to solve complicated decision problems in medicine, and plans to integrate his findings into new courses. "The research will introduce operations research tools to the medical community through a successful application of these tools to a complicated and controversial problem in medicine," he says.

He says there were a number of computational challenges he had to overcome in developing the model, and hopes to soon test it in a local clinic, although widespread clinical practice is likely several years away. "This is really very much still only on paper and in the computer," he says.

His description of the algorithm and how it works appeared in the journal Operations Research.

"Every model is a representation of a real life system," he says. "For this algorithm to work, we have to somehow represent the existence of cancer and probability of getting it over a lifetime."

For this, he used the so-called Markov decision process model, a popular operations research tool used in various areas of applications. His model only considers the present state--for example, the current condition of a patient--to predict the probability of a future state, in this case, the chances of a patient's developing cancer over a certain time period.

"There are already several risk assessment/predictions models that can tell you the probability of getting cancer over the next five or ten years, but this model also will consider your preferences and your risk and tell you at what age you should get a mammogram," Alagoz says. "Then it will tell you, if it is negative, you should get it at such and such an age. It makes a recommendation to you about when you should get your next mammogram and all kinds of other statistics."

The major difference between this model and other existing predictive algorithms "is that it takes into account how the woman feels about the procedure," he says, citing fears over mammography, the risk of false positives that could result in unnecessary biopsies and other tests. "We have to somehow translate your feelings into numbers, that is, how much quality of life is lost due to your feeling toward mammography, a false positive, a biopsy, and the possibility of breast cancer."

Alagoz hopes to include compliance as a factor in the next generation model. "What if she doesn't come back, how should we adjust our model to recommend more or less aggressive screening?" he says. "If compliance is very high, then less aggressive screening recommendations make more sense."

He also is using the model for investigating important screening policy questions such as what age to stop screening, what ages should be screened more aggressively, and the role of compliance in screening recommendations, among other things.

Alagoz is conducting his research with input from the medical community.

"The physicians are helping me build the models," he says. "When you build these models, you have to make some assumptions. I am not a physician, so I meet with physicians/epidemiologists every week who help me build the correct models."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Blueprint for the Affordable Genome
Stampede supercomputer powers innovations in DNA sequencing technologies.
Friday, June 27, 2014
'Smuggling' Drugs at the Cellular Level
Drexel researchers use ultrasound to deliver customized medication through the skin.
Wednesday, December 11, 2013
Identifying the Pathway that Leads to Cells Forming into an Individual Body
By studying how genes influence cells to migrate and mutate, scientist hopes findings will lead to improved cancer treatments.
Wednesday, December 11, 2013
Nanogrid, Activated by Sunlight, Breaks Down Pollutants in Water
Oil spills do untold damage to the environment, the waters they pollute and to marine and other wildlife.
Monday, November 11, 2013
One Day, we May Fill the Tank with Fungi Fuel!
Plant fungi and bacteria called "endophytes" fueling breakthroughs in energy, medicine and more.
Wednesday, September 25, 2013
Understanding how our Genes Help us Develop
Humans and fruit flies have similar Hox genes, which are master regulators of embryonic development.
Monday, September 16, 2013
US and UK Scientists Collaborate to Design Crops of the Future
Three Ideas Lab projects and a fourth NSF-sponsored project aim to transform future farming while reducing pollution and energy consumption.
Thursday, August 22, 2013
Cactus "Flesh" Cleans Up Toxic Water
Prickly pear cacti may be natural, cheaper answer to water cleanup.
Tuesday, August 13, 2013
Genomic and Computational Tools Provide Window to Distant Past
Researcher studies gene differences in humans and other species to better understand timeline of genetic changes.
Friday, August 09, 2013
Bacterial DNA May Integrate Into Human Genome More Readily in Tumor Tissue
Gene transfer may play role in cancer, other diseases linked with DNA damage.
Thursday, June 27, 2013
GWC Technologies Awarded NSF Grant to Develop novel Protein Microarray Products
Grant accelerates development of the company’s Carbon-on-Metal technology for protein array analysis.
Friday, July 03, 2009
NSF Awards $14M to Advance Plant Genomic Research
Resources to be developed include genomic sequences, genetic markers, maps and expressed sequence collections.
Thursday, January 11, 2007
Nanoethics Researchers Awarded $250,000 from National Science Foundation
Three-year project to study ethics of human enhancement and nanotechnology.
Tuesday, September 26, 2006
NSF Awards $145,924 Grant to Williams College
The project will establish a laboratory at Williams for the collection of DNA sequence and genotype data.
Monday, November 21, 2005
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!